Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Peripheral cannabinoid receptor ligands in development at Japan Tobacco

March 16, 1999

Roberts acquires Lodine rights in the U.K. and Ireland

March 12, 1999

Vertex initiates phase I clinical trial with VX-745

March 11, 1999

Cypress Bioscience and Fresenius sign definitive agreement for Prosorba Column

March 11, 1999

Merck Frosst presents clinical data on COX-2 inhibitor at Canadian meeting

March 10, 1999

Microbial metabolite inhibits ICAM-1/LFA-1-mediated cell adhesion

March 8, 1999

Cyclooxygenase-inhibitory indoles under study at Pfizer

March 8, 1999

Cytokine production inhibitors prepared and tested at Ortho-McNeil

March 4, 1999

Medarex joins forces with Danish investors to develop human antibody therapeutics

March 4, 1999

Cysteine protease-inhibitory peptides disclosed by Takeda

March 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...